Galmed Pharmaceuticals Announces Acceleration of its New Clinical Amilo-5MER program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/28/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. P
7. KKR
8. HPQ
9. NTNX
10. SNPS

Go back to Galmed Pharmaceuticals Announces Acceleration of its New Clinical Amilo-5MER program
GALMED PHARMACEUTIC (NASDAQ: GLMD) Delayed: 4.31 -0.02 (0.46%)
Previous Close $4.33    52 Week High $9.70 
Open $4.29    52 Week Low $2.78 
Day High $4.38    P/E N/A 
Day Low $4.16    EPS $0.00 
Volume 6,118       

GOLDEN POND HEALTHCARE, Inc. (AMEX: GPH) Delayed: 7.88 --0 (-0%)
Previous Close $7.88    52 Week High $7.95 
Open $19.32    52 Week Low $7.13 
Day High $7.88    P/E N/A 
Day Low $7.88    EPS $-0.03 
Volume 120,213       

GOLDEN POND HEALTHCARE, Inc. (AMEX: GPH) Delayed: 7.88 --0 (-0%)
Previous Close $7.88    52 Week High $7.95 
Open $19.32    52 Week Low $7.13 
Day High $7.88    P/E N/A 
Day Low $7.88    EPS $-0.03 
Volume 120,213       

GOLDEN POND HEALTHCARE, Inc. (AMEX: GPH) Delayed: 7.88 --0 (-0%)
Previous Close $7.88    52 Week High $7.95 
Open $19.32    52 Week Low $7.13 
Day High $7.88    P/E N/A 
Day Low $7.88    EPS $-0.03 
Volume 120,213